NasdaqCM:PLSEMedical Equipment
Pulse Biosciences (PLSE): Evaluating Valuation Following FDA Approval and Positive Thyroid Study Updates
If you have been eyeing Pulse Biosciences (PLSE), the latest developments may be just what prompts you to revisit the stock. The recent FDA approval for the company’s Investigational Device Exemption has cleared a major hurdle and now allows Pulse Biosciences to start a clinical study of its nsPFA Cardiac Surgery System in patients with atrial fibrillation. In addition, some encouraging initial results from their study on benign thyroid nodule treatment make it easy to see why investors are...